Archimedes US$100M , PTV News: Mar 03, 2010

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Archimedes US$100M , PTV News: Mar 03, 2010
Released on: March 03, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Follow us:
  • Summary
  • Transcript
  • Participants
  • Company
Biggest funding round by a Euro biopharma in 15 years
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Steven Renwick

Steven is a transactions specialist with experience in asset divestments and IP screening and sourcing, as well as competitive analysis and licensing litigation cases wherein PharmaVentures served as expert witness. He also conducts research on industry licensing practices and has presented this work internationally. Previously, Steven managed PharmaVentures’ Strategic Intelligence division, with responsibility for the development and production of PharmaDeals®. Steven has a BSc (Hons) in Biochemistry from the University of Dundee and a PhD in Genetics from University College London.
Archimedes Pharma Ltd
Archimedes is a European specialty pharmaceutical company with an established commercial organisation in the UK, France, Germany, Ireland and Spain and a portfolio of products marketed to specialist prescribers. Archimedes is growing its commercial presence through the acquisition of pharmaceutical companies and brands in Europe, and through partnering with companies to drive sales of their innovative products. In parallel, Archimedes is developing a robust pipeline of novel near and longer-term products to support its commercial organisation.